Invention Grant
US08975250B2 5 oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases
有权
5氧代-5,8-二氢吡啶并[2,3-d]嘧啶衍生物作为治疗心血管疾病的CaMKII激酶抑制剂
- Patent Title: 5 oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases
- Patent Title (中): 5氧代-5,8-二氢吡啶并[2,3-d]嘧啶衍生物作为治疗心血管疾病的CaMKII激酶抑制剂
-
Application No.: US13544209Application Date: 2012-07-09
-
Publication No.: US08975250B2Publication Date: 2015-03-10
- Inventor: Philippe Beauverger , Guillaume Begis , Sandrine Biscarrat , Olivier Duclos , Gary McCort
- Applicant: Philippe Beauverger , Guillaume Begis , Sandrine Biscarrat , Olivier Duclos , Gary McCort
- Applicant Address: FR Paris
- Assignee: SANOFI
- Current Assignee: SANOFI
- Current Assignee Address: FR Paris
- Agency: Scully, Scott, Murphy & Presser P.C.
- Priority: FR1050103 20100108
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/519 ; A61K31/496 ; A61K31/5377 ; A61K31/541 ; A61K31/551 ; A61P1/16 ; A61P13/12 ; A61P25/00 ; A61P25/16 ; A61P25/28 ; A61P29/00 ; A61P9/00 ; A61P9/06 ; A61P9/10 ; C07D239/47
![5 oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives as CaMKII kinase inhibitors for treating cardiovascular diseases](/abs-image/US/2015/03/10/US08975250B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to 5-oxo-5,8-dihydropyrido[2,3-d]pyrimidine derivatives having Formula (I) as defined herein, their preparation and their therapeutic use.
Public/Granted literature
Information query